Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment

Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment

Bibliographic Details
Main Authors:	Zappasodi, Roberta, Budhu, Sadna, Schaer, David, Yang, Xia, Zhong, Hong, Merghoub, Taha, Wolchok, Jedd D
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292527/

Similar Items

Blockade of Treg derived TGF-β abrogates suppression of effector T cell function within the tumor microenvironment
by: Budhu, Sadna, et al.
Published: (2013)

Blockade of surface bound TGF-β abrogates Treg suppression of effector T cell function within the tumor microenvironment
by: Budhu, Sadna, et al.
Published: (2014)

Immunotherapy and the belly of the beast
by: Merghoub, Taha, et al.
Published: (2014)

Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy
by: Khalil, Danny, et al.
Published: (2015)

The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment
by: Sharma, Madhav D., et al.
Published: (2015)

Myeloid-derived suppressor cells and the efficacy of CD8+ T-cell immunotherapy
by: Lesokhin, Alexander M., et al.
Published: (2013)

GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation
by: Xiao, Xiang, et al.
Published: (2015)

CD8+ T Cells: GITR Matters
by: Ronchetti, Simona, et al.
Published: (2012)

The PTEN pathway in Tregs functions as a critical driver of the immunosuppressive tumor microenvironment and tolerance to apoptotic cells
by: Sharma, Madhav, et al.
Published: (2015)

Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype
by: Hirschhorn-Cymerman, Daniel, et al.
Published: (2012)

Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
by: Holmgaard, Rikke B., et al.
Published: (2016)

Potentiation of immunomodulatory antibodies with oncolytic viruses for therapy of poorly-immunogenic tumors
by: Zamarin, Dmitriy, et al.
Published: (2014)

Expression of indoleamine 2.3-dioxygenase by tumors induces local and systemic immunosuppressive effects in a murine melanoma model
by: Holmgaard, Rikke B, et al.
Published: (2014)

Hiding the road signs that lead to tumor immunity
by: Schaer, David A., et al.
Published: (2011)

Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
by: Schaer, David A, et al.
Published: (2014)

Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression
by: López-Abente, Jacobo, et al.
Published: (2016)

Pharmacodynamic analysis of an agonistic antibody to the costimulatory receptor GITR
by: Moody, Gordon, et al.
Published: (2015)

Detection of Intra-Tumor Self Antigen Recognition during Melanoma Tumor Progression in Mice Using Advanced Multimode Confocal/Two Photon Microscope
by: Schaer, David A., et al.
Published: (2011)

Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccination
by: Schreiber, Taylor H., et al.
Published: (2012)

Multiple treg suppressive modules and their adaptability
by: Wing, James B., et al.
Published: (2012)

Murine B Cell Development and Antibody Responses to Model Antigens Are Not Impaired in the Absence of the TNF Receptor GITR
by: Sinik Teodorovic, Lenka, et al.
Published: (2012)

Localized oncolytic virotherapy inflames distant tumors and synergizes with immune checkpoint blockade leading to systemic tumor rejection
by: Zamarin, Dmitriy, et al.
Published: (2013)

GITR Activation Positively Regulates Immune Responses against Toxoplasma gondii
by: Costa, Frederico R. C., et al.
Published: (2016)

The use of anti-GITR antibody treatment in a murine model of glioblastoma multiforme
by: Miska, Jason, et al.
Published: (2015)

Expression of GITR Enhances Multiple Myeloma Cell Sensitivity to Bortezomib
by: Zhao, Yinghao, et al.
Published: (2015)

Molecular Mechanisms of Treg-Mediated T Cell Suppression
by: Schmidt, Angelika, et al.
Published: (2012)

Tumor antigens for cancer immunotherapy: therapeutic potential of xenogeneic DNA vaccines
by: Srinivasan, Roopa, et al.
Published: (2004)

Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
by: Zamarin, Dmitriy, et al.
Published: (2014)

DRhigh+CD45RA−-Tregs Potentially Affect the Suppressive Activity of the Total Treg Pool in Renal Transplant Patients
by: Schaier, Matthias, et al.
Published: (2012)

Ligation of CD38 suppresses human B lymphopoiesis
Published: (1995)

T cells translate individual, quantal activation into collective, analog cytokine responses via time-integrated feedbacks
by: Tkach, Karen E, et al.
Published: (2014)

Mechanisms of Treg Suppression: Still a Long Way to Go
by: Vignali, Dario A. A.
Published: (2012)

IL-35 improves Treg-mediated immune suppression in atherosclerotic mice
by: Tao, Linlin, et al.
Published: (2016)

CCL22 to activate Treg migration and suppress depigmentation in vitiligo
by: Eby, Jonathan M., et al.
Published: (2015)

TGF-β1 contributes to CD8+ Treg induction through p38 MAPK signaling in ovarian cancer microenvironment
by: Wu, Meng, et al.
Published: (2016)

Tumor microenvironment in NSCLC suppresses NK cells function
by: Cremer, Isabelle, et al.
Published: (2012)

GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
by: Muriglan, Stephanie J., et al.
Published: (2004)

The intracellular portion of GITR enhances NGF-promoted neurite growth through an inverse modulation of Erk and NF-κB signalling
by: McKelvey, Laura, et al.
Published: (2012)

Novel Tumor Suppressor Function of Glucocorticoid-Induced TNF Receptor GITR in Multiple Myeloma
by: Liu, Yang, et al.
Published: (2013)

Correlation of Increased Blood Levels of GITR and GITRL with Disease Severity in Patients with Primary Sjögren's Syndrome
by: Gan, Xiaoxia, et al.
Published: (2013)